Lausanne, Switzerland (ots) - - Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive form of Non-Hodgkin’s Lymphoma (NHL), representing 30-40% of cases. Nearly half of DLBCL patients are not cured by first-line treatment, leaving a large number of patients at risk of worsening disease1 - Naratuximab ...
Lausanne (ots) - For over a year now, many associations and bodies involved in the areas of social welfare, sport and culture have been battling to deal with repercussions from the public-health crisis. In response to this challenging predicament, Loterie Romande is delighted to announce it will be distributing CHF 224.7 million for public-interest projects, on a par with the figure for the previous year, even though ...
Schweizerischer Nationalfonds / Fonds national suisse
Bern (ots) - In 2020, researchers submitted 8200 grant applications to the SNSF. 3300 of them were selected for funding in a competitive process. At short notice, the SNSF funded 73 projects on COVID-19. Thousands of SNSF-funded teams explore nature, technology and society. This generates knowledge that is a key driver of progress. In 2020, the SNSF invested 937 million francs in 3300 new projects, selected from 8200 ...
Lausanne, Switzerland (ots/PRNewswire) - - Launching in May, an inaugural four-part webinar series Unmasking Facial Skin & Dermatoses will feature expert presentations from world-renowned dermatologists - The program launches the Galderma Excellence in Multichannel Medical Education (GEMME) platform, demonstrating ...
Lausanne, Switzerland (ots/PRNewswire) - - Rosacea sufferers join forces this Rosacea Awareness Month to bravely share the personal impact essential COVID-19 mask-wearing has on their skin condition - #RosaceaUnmasked encourages rosacea sufferers to speak with a doctor or dermatologist about the burden of regular ...
Lausanne, Switzerland (ots) - - Currently approved COVID-19 vaccines based on messenger RNA (mRNA) technology require two injections, given several weeks apart, for optimal protection against the virus - Debiopharm has launched a vaccine innovation challenge to a pool of international “problem Solvers” within ...
Lausanne, Switzerland (ots/PRNewswire) - Sommet Educationis the only hospitality education group with two Swiss higher education institutions, Glion and Les Roches, in the top four for Hospitality and Leisure Management education in the QS World University Rankings 2021. According to global higher education analysts ...
Lausanne, Switzerland and Seongnam-si Gyeonggi-do, Republic of Korea (ots) - Korean and Swiss based companies leverage their oncology expertise to initiate a research collaboration to formulate novel antibody-drug conjugate (ADC) candidates Genome & Company (314130, CEO: Jisoo Pae, Hansoo Park), a global leading ...
Lausanne, Switzerland (ots/PRNewswire) - - Although essential for public health, new online survey findings show that people with self-reported rosacea* may be experiencing worsening of symptoms due to mask wearing, further increasing the daily burden for people living with this chronic skin disease - Despite ...
Lausanne, Switzerland (ots/PRNewswire) - Sommet Education, the Leading Education Group in Hospitality with Glion Institute of Higher Education, Les Roches and Ecole Ducasse, has created a one-of-a-kind virtual student Fair around hospitality, culinary and pastry arts, luxury, innovation, digital programs. Glion, Les Roches and École Ducasse offer an exceptional portfolio of graduate and post-graduate programs focusing on ...
Lausanne, Switzerland and Boston (ots/PRNewswire) - SOPHiA GENETICS, a global leader in Data-Driven Medicine, announced today a clinical research partnership initiative with the Spanish Lung Cancer Group to apply its radiomics and multimodal analysis capabilities to predict response to neoadjuvant chemoimmunotherapy ...
Boston and Lausanne, Switzerland (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Kathy L. Hibbs was nominated to the company's Board of Directors and its Audit Committee. Hibbs is an accomplished healthcare technology executive, currently holding the position of Chief Legal ...
Tel Aviv, Israel / Lausanne, Switzerland (ots) - Nucleai (www.Nucleaimd.com), a global provider in pathology-based biomarker discovery, and Debiopharm (www.debiopharm.com), a Swiss-based biopharmaceutical company specializing in drug development, announced that they have entered into a long-term collaboration to ...
Boston and Lausanne, Switzerland (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Bram Goorden joined its Executive team, holding the dual role of Chief Commercial Officer and Head of North America. Goorden comes to SOPHiA from Foundation Medicine Inc. (Cambridge, MA) where he held the role of VP of International Business and ...
Geneva (ots/PRNewswire) - Firmenich, the world's largest privately owned fragrance and taste company, has introduced the industry's first laundry care fragrances that fuse Artificial Intelligence (AI) with human creativity. Presented at a customer Sensorium(TM) in Hangzhou, China during the China Cleaning Industry Association (CCIA) conference, the AI-augmented ...
Lausanne (ots) - For its sixteenth edition, the JCA-Mauvernay Award was awarded to Doctor Hideaki Ogiwara and Doctor Keisuke Kataoka Debiopharm (www.debiopharm.com), a Swiss-based global, biopharmaceutical company, presented the JCA-Mauvernay Award on October 3rd to Dr. Hideaki Ogiwara from the Division of Cancer Therapeutics of the National Cancer Center Research ...
Lausanne, Switzerland (ots) - First patient dosed in the randomized, placebo-controlled Phase III study of xevinapant (Debio 1143) vs placebo when added to chemoradiotherapy (CRT) in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) Debiopharm (www.debiopharm.com), a ...
Lausanne, Switzerland and Boston (ots/PRNewswire) - Supporting the Company's Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine - SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round exceeding $110 million, led by major health-tech fund and followed by strategic industry leader - Company ...
Lausanne, Switzerland (ots) - Debiopharm, (www.debiopharm.com), a Swiss-based biopharmaceutical company today announced being one of the recipients of the 2020 Swiss Biotech Success Story Award for exceptional achievements in the biotech industry. Every year, the Swiss Biotech Association awards companies or ...
Lausanne, Switzerland (ots) - Debiopharm announces the presentation of the 3-year phase II follow-up data along with 2 posters for xevinapant (antagonist of IAP -Inhibitor of Apoptosis Proteins) and WEE1 inhibitor Debio 0123 Debiopharm, ...
Euro Airport Basel-Mulhouse-Freiburg
Lausanne (ots) - First patient dosed in the phase I small cell lung cancer (SCLC) trial with Debio 1124, a molecular-targeted radiotherapy Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, today announced the first patient dosed in the multicenter, single-arm, open-label Phase 1 study ...
Lausanne, Switzerland (ots) - Promising overall survival outcomes at 3-years for high-risk, locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) patients observed with Debio 1143 + CRT Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, today announced the release of ...
Schweizerischer Nationalfonds / Fonds national suisse
Bern (ots) - New research has been launched to better control COVID-19. 18.6 million francs have been invested in projects that will investigate innovative solutions and develop public health recommendations. Mandated by the Federal Council, the SNSF launched the National Research Programme "COVID-19" (NRP 78) on 30 April 2020 to advance our understanding of the ...
Tel Aviv, Israel, Lausanne, Switzerland (ots) - - Nucleai, a computational biology company providing an AI-powered precision oncology platform for research and treatment decisions, secured $6.5M Series A initial closing. - Debiopharm's strategic corporate venture capital fund led the round joined by existing ...
Euroclear Holding, Euroclear Investments, Euroclear SA/NV
Brussels (ots/PRNewswire) - The Euroclear group announces that Marc Antoine Autheman has decided to step down as the Chairman and Director of the Euroclear boards. During Mr Autheman's eight year tenure, Euroclear's strategy has resulted in its strong financial position and performance, delivering consistently growing returns for shareholders and value for its financial market participants, whilst adapting to meet the requirements of the post-financial crisis regulatory and ...
Lausanne, Switzerland (ots/PRNewswire) - Healthcare professionals (HCPs) encouraged to investigate true impacts beyond the visible, empower patients with knowledge and aim for 'clear' (IGA 0) skin to improve outcomes A new expert-authored Galderma report (https://hosted.bmj.com/rosaceabeyondthevisible) released ...